Aadigen, LLC

10 patents currently held · Updated Nov 14, 2026

1 more in force is now held by another company

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Apr 2032

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Nov 14, 2026
The maintenance fee for Cell penetrating peptides for intracellular delivery of molecules (US 10,287,581) comes due Nov 14, 2026. Unpaid by May 14, 2027, it lapses early.
1 fee due Feb 1, 2027
The maintenance fee for Peptides and nanoparticles for intracellular delivery of molecules (US 11,713,336) comes due Feb 1, 2027. Unpaid by Aug 2, 2027, it lapses early.
1 fee due Mar 24, 2027
The maintenance fee for Cell penetrating peptides for intracellular delivery of molecules (US 10,421,784) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Patent	Title	Status	Expires	Confidence
US 9,376,468	Cell Penetrating Peptides for Intracellular Delivery of Molecules In force Term ends Apr 4, 2032 · High confidence	In force	Term ends Apr 4, 2032	High confidence
US 10,287,581	Cell penetrating peptides for intracellular delivery of molecules In force Ends no later than Apr 4, 2032 · From the USPTO record	In force	Ends no later than Apr 4, 2032	From the USPTO record
US 9,579,395	Cell penetrating peptides for intracellular delivery of molecules In force Term ends Oct 4, 2033 · From the USPTO record	In force	Term ends Oct 4, 2033	From the USPTO record
US 9,598,465	Cell penetrating peptides for intracellular delivery of molecules In force Term ends Oct 4, 2033 · From the USPTO record	In force	Term ends Oct 4, 2033	From the USPTO record
US 10,111,965	Cell Penetrating Peptides for Intracellular Delivery of Molecules In force Ends no later than Oct 4, 2033 · Low confidence	In force	Ends no later than Oct 4, 2033	Low confidence
US 10,421,784	Cell penetrating peptides for intracellular delivery of molecules In force Ends no later than Oct 4, 2033 · From the USPTO record	In force	Ends no later than Oct 4, 2033	From the USPTO record
US 10,745,440	Peptides and nanoparticles for intracellular delivery of molecules In force Term ends Dec 23, 2035 · From the USPTO record	In force	Term ends Dec 23, 2035	From the USPTO record
US 11,713,336	Peptides and nanoparticles for intracellular delivery of molecules In force Term ends Jun 27, 2036 · From the USPTO record	In force	Term ends Jun 27, 2036	From the USPTO record
US 12,357,695	Peptides and Nanoparticles for Intracellular Delivery of Molecules In force Term ends May 25, 2041 · High confidence	In force	Term ends May 25, 2041	High confidence
US 12,774,463	Compositions for Treating Cancer with Kras Mutations and Uses Thereof In force Term ends Aug 14, 2043 · High confidence	In force	Term ends Aug 14, 2043	High confidence

Also on record, not counted in the 10: 1 patent in force now held by others · 3 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 1 abandoned · 5 no status recorded

List them